United States - English - NLM (National Library of Medicine)

bausch health us, llc - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - pyridostigmine bromide 60 mg in 5 ml - mestinon is contraindicated in mechanical intestinal or urinary obstruction, and particular caution should be used in its administration to patients with bronchial asthma. care should be observed in the use of atropine for counteracting side effects, as discussed below.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - pyridostigmine bromide, quantity: 60 mg - tablet, sugar coated - excipient ingredients: iron oxide yellow; colloidal anhydrous silica; acacia; magnesium stearate; maize starch; povidone; liquid paraffin; purified talc; rice starch; hard paraffin; iron oxide red; sucrose; pregelatinised potato starch - indications as at 3 august 1992: mestinon is useful in the treatment of myasthenia gravis.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - pyridostigmine bromide, quantity: 180 mg - tablet, modified release - excipient ingredients: zein; carnauba wax; colloidal anhydrous silica; magnesium stearate; calcium phosphate - indications as at 3 august 1992: mestinon is useful in the treatment of myasthenia gravis.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - pyridostigmine bromide, quantity: 10 mg - tablet, uncoated - excipient ingredients: magnesium stearate; maize starch; purified talc; lactose monohydrate; colloidal anhydrous silica; pregelatinised potato starch - indications as at 3 august 1992: mestinon is useful in the treatment of myasthenia gravis.

Israel - English - Ministry of Health

megapharm ltd - pyridostigmine bromide - dragee - pyridostigmine bromide 60.0 mg - pyridostigmine - pyridostigmine - treatment of myasthenia gravis.

New Zealand - English - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - pyridostigmine bromide 60mg equivalent to a 2% overage is added during manfuacuture;   - tablet - 60 mg - active: pyridostigmine bromide 60mg equivalent to a 2% overage is added during manfuacuture   excipient: colloidal silicon dioxide lactose stearic acid - myasthenia gravis; paralytic ileus; postoperative urinary retention.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - pyridostigmine bromide - oral tablet - 60mg

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

a. menarini singapore pte. ltd. - pyridostigmine bromide -

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals australia pty ltd - pyridostigmine bromide -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - pyridostigmine bromide - oral tablet - 60mg